• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990 - 2019年全球、区域和国家癫痫负担的时间趋势:全球疾病负担研究2019的年龄-时期-队列分析

Global, regional, and national time trends in the burden of epilepsy, 1990-2019: an age-period-cohort analysis for the global burden of disease 2019 study.

作者信息

Shan Tao, Zhu Yahui, Fan Haozhi, Liu Zeye, Xie Jing, Li Mao, Jing Shenqi

机构信息

Department of Outpatient, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.

School of Information Management, Nanjing University, Nanjing, China.

出版信息

Front Neurol. 2024 Aug 15;15:1418926. doi: 10.3389/fneur.2024.1418926. eCollection 2024.

DOI:10.3389/fneur.2024.1418926
PMID:39233683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11373253/
Abstract

BACKGROUND

Epilepsy is a non-communicable chronic brain disease that affects all age groups. There are approximately 50 million epilepsy patients worldwide, which is one of the most common neurological disorder. This study reports the time trends in the burden of epilepsy from 1999 to 2019.

METHODS

We evaluated the disease burden and its temporal trends of epilepsy using the prevalence and years lived with disability (YLDs), which was estimated based on the Global Burden of Disease (GBD) 2019 study. The age-period-cohort (APC) model was used to estimate the temporal trends of the epilepsy prevalence and YLDs rates, and to analyze the relative risks of age, periods and queues (age/period/queue effects).

RESULTS

In the past 30 years, the global age-standardized prevalence rate and age-standardized rate has increased by 29.61% and 27.02%, respectively. Globally, the APC model estimated the net drift of prevalence and YLDs were 0.88% (95% CI: 0.83-0.93) and 0.80% (95% CI: 0.75-0.85) per year. Among 204 countries and territories, the YLDs in 146 and prevalence 164 showed an increasing trend. And the risk of YLDs and prevalence increases with age, with the lowest risk among 0-4 years old and the highest risk among 75-79 years old. Unfavorable increasing period and cohort risks of YLDs and prevalence were observed.

CONCLUSION

Over the past 30 years, the YLDs and prevalence of epilepsy have gradually increased globally and unfavorable increasing period and cohort risks were observed. Emphasizing epilepsy prevention, strengthening epilepsy health education, optimizing older adults epilepsy diagnosis and treatment plans, and actively promoting epilepsy diagnosis and treatment plans can effectively reduce new cases of epilepsy and related disabilities.

摘要

背景

癫痫是一种影响所有年龄组的非传染性慢性脑病。全球约有5000万癫痫患者,是最常见的神经系统疾病之一。本研究报告了1999年至2019年癫痫负担的时间趋势。

方法

我们使用患病率和伤残调整生命年(YLDs)评估癫痫的疾病负担及其时间趋势,这是根据《2019年全球疾病负担》(GBD)研究估计的。年龄 - 时期 - 队列(APC)模型用于估计癫痫患病率和YLDs率随时间的变化趋势,并分析年龄、时期和队列的相对风险(年龄/时期/队列效应)。

结果

在过去30年中,全球年龄标准化患病率和年龄标准化率分别上升了29.61%和27.02%。在全球范围内,APC模型估计患病率和YLDs的年净变化率分别为0.88%(95%CI:0.83 - 0.93)和0.80%(95%CI:0.75 - 0.85)。在204个国家和地区中,146个地区的YLDs和164个地区的患病率呈上升趋势。YLDs和患病率的风险随年龄增长而增加,0 - 4岁风险最低,75 - 79岁风险最高。观察到YLDs和患病率存在不利的时期和队列增加风险。

结论

在过去30年中,全球癫痫的YLDs和患病率逐渐上升,并观察到不利的时期和队列增加风险。强调癫痫预防、加强癫痫健康教育、优化老年人癫痫诊断和治疗方案,积极推广癫痫诊断和治疗方案,可以有效减少癫痫新发病例和相关残疾。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88a/11373253/ef6b3f3b6311/fneur-15-1418926-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88a/11373253/75235a52cae5/fneur-15-1418926-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88a/11373253/aeb4954fcd08/fneur-15-1418926-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88a/11373253/f2670b1d16be/fneur-15-1418926-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88a/11373253/ce11dd5c435d/fneur-15-1418926-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88a/11373253/a60f3bf21721/fneur-15-1418926-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88a/11373253/a89bd814fa62/fneur-15-1418926-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88a/11373253/ef6b3f3b6311/fneur-15-1418926-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88a/11373253/75235a52cae5/fneur-15-1418926-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88a/11373253/aeb4954fcd08/fneur-15-1418926-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88a/11373253/f2670b1d16be/fneur-15-1418926-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88a/11373253/ce11dd5c435d/fneur-15-1418926-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88a/11373253/a60f3bf21721/fneur-15-1418926-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88a/11373253/a89bd814fa62/fneur-15-1418926-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88a/11373253/ef6b3f3b6311/fneur-15-1418926-g007.jpg

相似文献

1
Global, regional, and national time trends in the burden of epilepsy, 1990-2019: an age-period-cohort analysis for the global burden of disease 2019 study.1990 - 2019年全球、区域和国家癫痫负担的时间趋势:全球疾病负担研究2019的年龄-时期-队列分析
Front Neurol. 2024 Aug 15;15:1418926. doi: 10.3389/fneur.2024.1418926. eCollection 2024.
2
Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990-2019: an age-period-cohort analysis for the global burden of disease 2019 study.全球、地区和国家子宫纤维瘤发病率、患病率和残疾生存年数的时间趋势,1990-2019 年:对 2019 年全球疾病负担研究的年龄-时期-队列分析。
BMC Public Health. 2023 May 19;23(1):916. doi: 10.1186/s12889-023-15765-x.
3
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
4
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.1990年至2013年188个国家301种急慢性疾病和损伤的全球、区域及国家发病率、患病率和伤残调整生命年:全球疾病负担研究2013的系统分析
Lancet. 2015 Aug 22;386(9995):743-800. doi: 10.1016/S0140-6736(15)60692-4. Epub 2015 Jun 7.
5
Global, regional, and national burden of spinal cord injury, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家脊髓损伤负担,1990-2019 年:2019 年全球疾病负担研究的系统分析。
Lancet Neurol. 2023 Nov;22(11):1026-1047. doi: 10.1016/S1474-4422(23)00287-9.
6
The global, regional, and national burden of pancreatitis in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.1990 年至 2017 年全球 195 个国家和地区的胰腺炎负担:2017 年全球疾病负担研究的系统分析。
BMC Med. 2020 Dec 10;18(1):388. doi: 10.1186/s12916-020-01859-5.
7
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家层面 195 个国家和地区 1990 年至 2017 年 354 种疾病和伤害导致的发病率、患病率和伤残损失寿命年:基于 2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8.
8
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家 204 个地区 1990-2019 年 12 种精神障碍疾病的负担:基于 2019 年全球疾病负担研究的系统分析。
Lancet Psychiatry. 2022 Feb;9(2):137-150. doi: 10.1016/S2215-0366(21)00395-3. Epub 2022 Jan 10.
9
Estimation of the global prevalence, incidence, years lived with disability of rheumatoid arthritis in 2019 and forecasted incidence in 2040: results from the Global Burden of Disease Study 2019.估算 2019 年全球类风湿性关节炎的患病率、发病率、残疾年数和 2040 年预测发病率:来自 2019 年全球疾病负担研究的结果。
Clin Rheumatol. 2023 Sep;42(9):2297-2309. doi: 10.1007/s10067-023-06628-2. Epub 2023 Jun 9.
10
Trends and disparities in disease burden of age-related macular degeneration from 1990 to 2019: Results from the global burden of disease study 2019.1990 年至 2019 年与年龄相关的黄斑变性疾病负担的趋势和差异:2019 年全球疾病负担研究的结果。
Front Public Health. 2023 Apr 17;11:1138428. doi: 10.3389/fpubh.2023.1138428. eCollection 2023.

引用本文的文献

1
Global burden of hypertensive heart disease attributable to high body mass index from 1990 to 2021: a multidimensional analysis and public health response.1990年至2021年因高体重指数所致高血压性心脏病的全球负担:多维分析与公共卫生应对措施
Front Cardiovasc Med. 2025 Aug 12;12:1570390. doi: 10.3389/fcvm.2025.1570390. eCollection 2025.
2
Global, regional, and national burden of knee osteoarthritis: findings from the Global Burden of Disease study 2021 and projections to 2045.全球、区域和国家膝关节骨关节炎负担:全球疾病负担研究2021年的结果及到2045年的预测
J Orthop Surg Res. 2025 Aug 13;20(1):766. doi: 10.1186/s13018-025-06140-0.
3

本文引用的文献

1
Adult epilepsy.成人癫痫。
Lancet. 2023 Jul 29;402(10399):412-424. doi: 10.1016/S0140-6736(23)01048-6. Epub 2023 Jul 14.
2
Global, regional, and national burden and attributable risk factors of neurological disorders: The Global Burden of Disease study 1990-2019.全球、区域和国家神经障碍的负担和可归因风险因素:1990-2019 年全球疾病负担研究。
Front Public Health. 2022 Nov 29;10:952161. doi: 10.3389/fpubh.2022.952161. eCollection 2022.
3
Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
Global, regional, and national children and adolescent epilepsy burden, 1990-2021: an analysis based on the global burden of disease study 2021.
1990 - 2021年全球、区域和国家儿童及青少年癫痫负担:基于2021年全球疾病负担研究的分析
Ann Med. 2025 Dec;57(1):2534087. doi: 10.1080/07853890.2025.2534087. Epub 2025 Jul 17.
4
Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990-2036: cross-national health inequalities and predictive analytics.1990 - 2036年全球、区域和国家不明原因癫痫的发病率和死亡率:跨国健康不平等与预测分析
Front Neurol. 2025 Jun 30;16:1526984. doi: 10.3389/fneur.2025.1526984. eCollection 2025.
5
L-quebrachitol Modulates the Anti-convulsant Effects of Carbamazepine Possibly Through Voltage-gated Sodium Channel Blocking Mechanism in Chicks: In Vivo and In Silico Studies.L-昆布醇可能通过阻断雏鸡电压门控钠通道机制调节卡马西平的抗惊厥作用:体内和计算机模拟研究
Brain Behav. 2025 Jul;15(7):e70675. doi: 10.1002/brb3.70675.
6
Clinical and functional characterization of the GABRB3 p.Met80Val variant in early-onset epilepsy with long-term follow-up.早发性癫痫中GABRB3基因p.Met80Val变异体的临床及功能特征:长期随访研究
Ital J Pediatr. 2025 Jun 20;51(1):195. doi: 10.1186/s13052-025-02046-z.
7
Global, regional, and national burden of epilepsy, 1990-2021: a systematic analysis for the Global Burden of Disease Study in 2021.1990 - 2021年全球、区域和国家的癫痫负担:2021年全球疾病负担研究的系统分析
Cost Eff Resour Alloc. 2025 Jun 11;23(1):28. doi: 10.1186/s12962-025-00635-7.
8
Global, regional, and national burden of refraction disorders: findings from the global burden of disease study 2021 and projections to 2050.屈光不正疾病的全球、区域和国家负担:全球疾病负担研究2021的结果及到2050年的预测
BMC Public Health. 2025 Apr 2;25(1):1247. doi: 10.1186/s12889-025-22440-w.
1990—2019年全球、区域和国家的卒中负担及其风险因素:全球疾病负担研究2019的系统分析
Lancet Neurol. 2021 Oct;20(10):795-820. doi: 10.1016/S1474-4422(21)00252-0. Epub 2021 Sep 3.
4
Epilepsy in China: major progress in the past two decades.中国的癫痫:过去二十年的主要进展。
Lancet Neurol. 2021 Apr;20(4):316-326. doi: 10.1016/S1474-4422(21)00023-5. Epub 2021 Mar 17.
5
Burden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study.《1990-2017 年美国神经障碍疾病负担:全球疾病负担研究》
JAMA Neurol. 2021 Feb 1;78(2):165-176. doi: 10.1001/jamaneurol.2020.4152.
6
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1950-2019 年全球年龄性别特定生育率、死亡率、健康期望寿命(HALE)和人口估计值:2019 年全球疾病负担研究的综合人口分析。
Lancet. 2020 Oct 17;396(10258):1160-1203. doi: 10.1016/S0140-6736(20)30977-6.
7
Age period cohort analysis: a review of what we should and shouldn't do.年龄时期队列分析:关于我们应该做什么和不应该做什么的综述。
Ann Hum Biol. 2020 Mar;47(2):208-217. doi: 10.1080/03014460.2019.1707872.
8
Evaluation of a REDCap-based Workflow for Supporting Federal Guidance for Electronic Informed Consent.基于REDCap的工作流程评估,以支持联邦电子知情同意指南
AMIA Jt Summits Transl Sci Proc. 2019 May 6;2019:163-172. eCollection 2019.
9
Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家癫痫负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2019 Apr;18(4):357-375. doi: 10.1016/S1474-4422(18)30454-X. Epub 2019 Feb 14.
10
Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.1990 - 2015年全球、区域和国家神经系统疾病负担:全球疾病负担研究2015的系统分析
Lancet Neurol. 2017 Nov;16(11):877-897. doi: 10.1016/S1474-4422(17)30299-5. Epub 2017 Sep 17.